definiens: shall mean a Drug Candidate to which : ( a ) NN is granted the exclusive rights to develop and c ommercialize under this Agreement by virtue of such Drug Candidate having achieved at least M0 sta tus but less than M1 status as of either ( x ) the expiration of the * * * period following immediat ely a fter : ( i ) the expiration of the Collaboration Term pursuant t o Subsection 13.3.3, ( ii ) NN ’s termination of the Agreement prior to the expi ration of the Collaboration Term for an IPH Change of Control or other IPH Transfer, pur suant to Section 13.5, or ( iii ) NN ’s termination of the Agreement prior to the expi ration of the Collaboration Term for IPH ’s material breach pursuant to Section 13.7 ; or Certain information has been excluded from this agr eement ( indicated by ) because such informat ion ( i ) is not material and ( ii ) would be competitively har mful if publicly disclosed